NEFL and cerebral small vessel disease: Recently, many studies have indicated that NF-L in the cerebrospinal fluid (CSF) and bloodstream may serve as a reliable biomarker for the progression of age-related neurological disorders, including cerebral small vessel disease (CSVD) [4–6].